Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariella Spalato-Ceruso

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Hematology & Oncology|September 1, 2024
New strategies in soft tissue sarcoma treatmentMariella Spalato-Ceruso, Nathan El Ghazzi, Antoine Italiano
BMJ Case Reports|June 5, 2019
Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordomaMariella Spalato Ceruso, Andrea Napolitano, Marianna Silletta, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
New frontiers in the medical management of gastrointestinal stromal tumoursAlessandro Mazzocca, Andrea Napolitano, Marianna Silletta, et al.
Expert Opinion on Drug Safety|May 28, 2016
Drug-induced hepatotoxicity in cancer patients - implication for treatmentBruno Vincenzi, Grazia Armento, Mariella Spalato Ceruso, et al.
JCO Clinical Cancer Informatics|September 15, 2021
Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant ChemotherapyAmandine Crombé, Sophie Cousin, Mariella Spalato-Ceruso, et al.
Expert Review of Anticancer Therapy|June 27, 2015
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experienceBruno Vincenzi, Marco Imperatori, Antonio Picardi, et al.
Critical Reviews in Oncology/Hematology|September 18, 2017
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomasBruno Vincenzi, Giuseppe Badalamenti, Andrea Napolitano, et al.
Chemotherapy|August 8, 2019
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma PatientsMariella Spalato Ceruso, Andrea Napolitano, Marianna Silletta, et al.
Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.
Cancers|August 6, 2020
Recent Advances in Desmoid Tumor TherapyAndrea Napolitano, Alessandro Mazzocca, Mariella Spalato Ceruso, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Hematology & Oncology|September 1, 2024
New strategies in soft tissue sarcoma treatmentMariella Spalato-Ceruso, Nathan El Ghazzi, Antoine Italiano
BMJ Case Reports|June 5, 2019
Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordomaMariella Spalato Ceruso, Andrea Napolitano, Marianna Silletta, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
New frontiers in the medical management of gastrointestinal stromal tumoursAlessandro Mazzocca, Andrea Napolitano, Marianna Silletta, et al.
Expert Opinion on Drug Safety|May 28, 2016
Drug-induced hepatotoxicity in cancer patients - implication for treatmentBruno Vincenzi, Grazia Armento, Mariella Spalato Ceruso, et al.
JCO Clinical Cancer Informatics|September 15, 2021
Implementing a Machine Learning Strategy to Predict Pathologic Response in Patients With Soft Tissue Sarcomas Treated With Neoadjuvant ChemotherapyAmandine Crombé, Sophie Cousin, Mariella Spalato-Ceruso, et al.
Expert Review of Anticancer Therapy|June 27, 2015
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experienceBruno Vincenzi, Marco Imperatori, Antonio Picardi, et al.
Critical Reviews in Oncology/Hematology|September 18, 2017
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomasBruno Vincenzi, Giuseppe Badalamenti, Andrea Napolitano, et al.
Chemotherapy|August 8, 2019
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma PatientsMariella Spalato Ceruso, Andrea Napolitano, Marianna Silletta, et al.
Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.
Cancers|August 6, 2020
Recent Advances in Desmoid Tumor TherapyAndrea Napolitano, Alessandro Mazzocca, Mariella Spalato Ceruso, et al.
Pageof 3